EUPRAXIA PHARMACEUTICALS INC.
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
EPRX | NDAQ
Overview
Corporate Details
- ISIN(s):
 - N/A
 - LEI:
 - Country:
 - United States of America
 - Address:
 - 201-2067 CADBORO BAY RD., VICTORIA
 - Sector:
 - Manufacturing
 - Industry:
 - Manufacture of pharmaceuticals, medicinal chemical and botanical products
 
Description
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company developing targeted therapies through its proprietary Diffusphere™ drug delivery platform. This extended-release technology is engineered to deliver medication precisely to the site of disease, aiming to maximize efficacy and duration while minimizing systemic side effects. The company's clinical pipeline is focused on high-need indications in gastrointestinal and musculoskeletal diseases. Its lead candidate, EP-104GI, is in development for the treatment of Eosinophilic Esophagitis (EoE), with other programs targeting joint pain and related disorders. Eupraxia's patient-centric approach seeks to improve treatment outcomes by providing long-acting, localized therapies for conditions where current standards of care are insufficient.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all EUPRAXIA PHARMACEUTICALS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EUPRAXIA PHARMACEUTICALS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EUPRAXIA PHARMACEUTICALS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||